Search

Author/Creator Ayoub, Jean-Pierre

1. Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy. (June 2018)

Authors:
Bradbury, Penelope A.; Morris, Donald G.; Nicholas, Garth; Tu, Dongsheng; Tehfe, Moustapha; Goffin, John R.; Shepherd, Frances A.; Gregg, Richard W.; Rothenstein, Jeffrey; Lee, Christoper; Kuruvilla, Sara; Keith, Bruce D.; Torri, Vamsee; Blais, Normand; Hao, Desiree; Korpanty, Grzegorz J.; Goss, ...
Journal:
Lung cancer
Issue:
Volume 120(2018)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial. (September 2021)

Authors:
Arun, Banu K.; Han, Hyo S.; Kaufman, Bella; Wildiers, Hans; Friedlander, Michael; Ayoub, Jean-Pierre; Puhalla, Shannon L.; Bell-McGuinn, Katherine M.; Bach, Bruce A.; Kundu, Madan G.; Ratajczak, Christine K.; Maag, David; Diéras, Véronique
Journal:
European journal of cancer
Issue:
Volume 154(2021)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM). (4th November 2015)

Authors:
Lapointe, Réjean; Jamal, Rahima; van Kempen, Leon; Thebault, Pamela; Belanger, Karl; Friedmann, Jennifer; Ayoub, Jean-Pierre; Cocolakis, Eftihia; Kazemi, Shirin; Dionne, Jeanne; Lambert, Caroline; Le, Huy; Grange, Cecile; Cailhier, Jean-Francois; Spatz, Alan; Miller, Wilson
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM). Issue 2 (December 2015)

Authors:
Lapointe, Réjean; Jamal, Rahima; van Kempen, Leon; Thebault, Pamela; Belanger, Karl; Friedmann, Jennifer; Ayoub, Jean-Pierre; Cocolakis, Eftihia; Kazemi, Shirin; Dionne, Jeanne; Lambert, Caroline; Le, Huy; Grange, Cecile; Cailhier, Jean-Francois; Spatz, Alan; Miller, Wilson
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma. Issue 1 (21st November 2017)

Authors:
Jamal, Rahima; Lapointe, Réjean; Cocolakis, Eftihia; Thébault, Paméla; Kazemi, Shirin; Friedmann, Jennifer E.; Dionne, Jeanne; Cailhier, Jean-François; Bélanger, Karl; Ayoub, Jean-Pierre; Le, Huy; Lambert, Caroline; El-Hajjar, Jida; van Kempen, Léon C.; Spatz, Alan; Miller, Wilson H.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial. (December 2021)

Authors:
Ayoub, Jean-Pierre; Wildiers, Hans; Friedlander, Michael; Arun, Banu K.; Han, Hyo S.; Puhalla, Shannon; Shparyk, Yaroslav; Jakobsen, Erik H.; Wu, Meijing; Bach, Bruce A.; Feng, Dai; Ratajczak, Christine K.; Maag, David; Diéras, Véronique
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2020)

Authors:
Diéras, Véronique; Han, Hyo S; Kaufman, Bella; Wildiers, Hans; Friedlander, Michael; Ayoub, Jean-Pierre; Puhalla, Shannon L; Bondarenko, Igor; Campone, Mario; Jakobsen, Erik H; Jalving, Mathilde; Oprean, Cristina; Palácová, Marketa; Park, Yeon Hee; Shparyk, Yaroslav; Yañez, Eduardo; Khandelwal, N...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 10(2020)
Page Start:
1269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗